Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares shot up 17.6% during mid-day trading on Monday . The company traded as high as C$0.20 and last traded at C$0.20. 134,500 shares traded hands during mid-day trading, a decline of 48% from the average session volume of 256,409 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 4.23, a current ratio of 0.10 and a quick ratio of 0.84. The stock has a 50-day moving average price of C$0.16 and a 200-day moving average price of C$0.10. The company has a market capitalization of C$27.27 million, a price-to-earnings ratio of -16.84 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- Palantir Setting Up to Be a Big Winner With New Defense Spending
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Advanced Micro Devices Can Double in Price: Here’s Why
- What Are Earnings Reports?
- How Disney’s Experiences Segment Can Restore the House of Mouse
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
